Emily earned a Bachelor of Science in biotechnology from Rochester Institute of Technology in 2018, and a Master of Science in biomedical sciences with a focus in pharmacology from University of Colorado Anschutz Medical Campus in 2020. During her thesis work, she studied non-small cell lung cancer and how the immune system plays a role in response to different therapies. Emily is passionate about immunology, cancer biology, and molecular biology, and understanding how they relate to diseases.